Sector: Healthcare|Industry: Medical Distribution|Market Cap: $72.48B|Employees: 51K
McKesson Corporation is a diversified healthcare services leader that partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to deliver insights, products, and services to make quality care more accessible and affordable. The company operates in four segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International. McKesson's key markets include the U.S., Canada, and Europe, with a focus on supply chain excellence and innovative solutions.
Revenues increased to $80.9 billion, a 15% increase compared to $70.5 billion in the prior year quarter, primarily driven by market growth within the U.S. Pharmaceutical segment, including higher volumes from retail national account customers and growth in specialty pharmaceuticals.
Gross profit margin decreased to 3.90%, a 60 bps decline compared to 4.50% in the prior year quarter, driven by the divestiture of the E.U. disposal group within the International segment, partially offset by growth of specialty pharmaceuticals and increased contributions from generics programs.
Net income attributable to McKesson Corporation decreased to $589 million, a 45% decrease compared to $1.1 billion in the prior year quarter, primarily due to lower gross profit margin and higher operating expenses.